1Effects of primary microglia and astrocytes on neural stem cells in in vitro and in vivo models of ischemic strokeResearch Articles1677-1685
5Chronic peripheral inflammation:a possible contributor to neurodegenerative diseasesReviews1711-1714
7Considerations on the concept,definition,and diagnosis of amyotrophic lateral sclerosisReviews1723-1729
8Promising drug targets and associated therapeutic interventions in Parkinson's diseaseSachchida Nand Rai，Payal Singh，Ritu Varshney，Vivek K.Chaturvedi，Emanuel Vamanu，M.P.Singh，Brijesh Kumar SinghReviews1730-1739
10The future of retinal gene therapy:evolving from subretinal to intravitreal vector deliveryReviews1751-1759
11New insights on the molecular mechanisms of collateral sprouting after peripheral nerve injuryPerspectives1760-1761
13Sex,ApoE4 and Alzheimer's disease:rethinking drug discovery in the era of precision medicinePerspectives1764-1765
14Predictive models for mild cognitive impairment to Alzheimer's disease conversionPerspectives1766-1767
16Human stem cell-derived microglia will be an indispensable toolbox for Alzheimer's disease researchPerspectives1770-1771
17Preventative medicine and Alzheimer's disease:is Alzheimer's disease risk reduction achievable?Perspectives1772-1773
18The molecular implications of a caspase-2-mediated site-specific tau cleavage in tauopathiesPerspectives1774-1775
19Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegenerationPerspectives1776-1778
20A central role for mitochondrial-derived vesicles in the innate immune response:implications for Parkinson's diseasePerspectives1779-1780
